During the past decade, Cabinetul Medical Nicodiab SRL conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 6 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cabinetul Medical Nicodiab SRL" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Cabinetul Medical Nicodiab SRL" are "Diabetes Mellitus, Type 2" (3 trials), "Type 2 Diabetes Mellitus" (3 trials), "Diabetes Mellitus, Type 1" (1 trials), "Obesity" (1 trials) and "Overweight" (1 trials). Many other conditions were trialed in "Cabinetul Medical Nicodiab SRL" in a lesser frequency.

Most popular intervention types in "Cabinetul Medical Nicodiab SRL" are "Drug" (9 trials). Other intervention types were less common.

The name of intervention was led by "Tirzepatide" (5 trials), "Dulaglutide" (2 trials), "Placebo" (2 trials), "linagliptin" (2 trials) and "Empagliflozin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cabinetul Medical Nicodiab SRL" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Cabinetul Medical Nicodiab SRL". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Cabinetul Medical Nicodiab SRL, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cabinetul Medical Nicodiab SRL, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".